Bevaas 400/16
Bevaas is Hetero’s second monoclonal antibody and the third biosimilar product,
that is offering major relief for conditions such as Metastatic Colorectal Cancer,
Lung Cancer and Renal Cancer.
Bevaas is Hetero’s second monoclonal antibody and the third biosimilar product,
that is offering major relief for conditions such as Metastatic Colorectal Cancer,
Lung Cancer and Renal Cancer.
